AKTS — Aktis Oncology, Inc.
Price · 2024-08-26 → 2026-08-21
235 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2017-03-13.
Performance
Technicals
Others in Healthcare
Measured signals that fired on AKTS
| date | signal | measured base rate |
|---|---|---|
| 2026-06-22 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-06-16 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-03-20 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-20 | Herrmann Ken Director | Open-market sale | 3.5K | 24.56 | 86.1K |
| 2026-07-20 | Herrmann Ken Director | Open-market sale | 1.4K | 24.56 | 33.2K |
| 2026-07-20 | Herrmann Ken Director | Option exercise | 1.4K | 1.91 | 2.6K |
| 2026-07-20 | Herrmann Ken Director | Option exercise | 3.5K | 0.08 | 280 |
| 2026-07-17 | Herrmann Ken Director | Open-market sale | 3.1K | 25.21 | 77.3K |
| 2026-07-17 | Herrmann Ken Director | Option exercise | 3.1K | 0.08 | 245 |
| 2026-07-08 | Czibere Akos Chief Medical Officer | Open-market sale | 30.8K | 27.95 | 861.7K |
| 2026-07-08 | Ron-Bigger Shulamit Chief Operating Officer | Open-market sale | 30.0K | 27.94 | 838.1K |
| 2026-07-08 | Ron-Bigger Shulamit Chief Operating Officer | Open-market sale | 15.8K | 27.13 | 428.7K |
| 2026-07-08 | Czibere Akos Chief Medical Officer | Open-market sale | 14.8K | 27.13 | 401.5K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| MPM BIOIMPACT LLC | 86.5M | 4.8M |
| EcoR1 Capital, LLC | 86.3M | 4.8M |
| Blue Owl Capital Holdings LP | 56.6M | 3.2M |
| WELLINGTON MANAGEMENT GROUP LLP | 41.5M | 2.3M |
| BlackRock, Inc. | 37.8M | 2.1M |
| RTW INVESTMENTS, LP | 28.5M | 1.6M |
| RA CAPITAL MANAGEMENT, L.P. | 26.9M | 1.5M |
| JANUS HENDERSON GROUP PLC | 26.0M | 1.5M |
| BAKER BROS. ADVISORS LP | 17.8M | 996.4K |
| Octagon Capital Advisors LP | 17.2M | 960.8K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Micron and 15 Other Stocks To Play The AI Buildout Race: They Are Still 20% Below Highs · 2026-08-14 · benzinga
Ask the AI about AKTS
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →